BiondVax Pharmaceuticals (SCNI) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
Scinai Immunotherapeutics keng ko'lamli surunkali dermatologiya bozoridagi psoriazga chalingan shaxslarni nishonga olgan holda, teri yallig'lanishi terapiyasi uchun antitanalarni ishlab chiqishga ixtisoslashgan. Ushbu narxlar grafigi (separate_debt_long_eq) aktivning dinamikasini aks ettiradi, bunda joriy qiymat 0.28 ni tashkil etadi. Ishlab chiqarish quvvatlari murakkab oqsillarning sintezi paytida qo'l mehnatini minimallashtiradigan, yuqori aniqlik va jarayon xavfsizligini ta'minlaydigan avtomatlashtirilgan bioreaktorlarga asoslangan.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_SCNI_-_Scinai-Immunotherapeutics_-_Long-Term-Debt-to-Capital "SCNI: Scinai Immunotherapeutics Ltd. Uzoq muddatli qarzning kapitalga nisbati 21.02.2024 - 01.11.2026 | 👁️GURU.Markets👁️")
Scinai Immunotherapeutics (SCNI) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Scinai Immunotherapeutics|SCNI - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati scinai.com|SCNI - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Scinai Immunotherapeutics Ltd.|SCNI - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Scinai Immunotherapeutics|Tezkor likvidlik ko‘rsatkichi scinai.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:Scinai Immunotherapeutics Ltd - SCNI
Ushbu koeffitsient bir yildan ortiq muddatga moliyalashtirilgan majburiyatlarning kapitalga nisbatini o'lchaydi. Scinai Immunotherapeutics uchun ushbu ko'rsatkich daromadning yo'qligi va yuqori R&D xarajatlari tufayli juda muhimdir. Jori uzoq muddatli qarzning kapitalga nisbatini tahlil qilish orqali investorlar kompaniyaning moliyalashtirish tuzilmasining barqarorligini baholaydilar. Pastroq koeffitsient klinik sinovlar muvaffaqiyatsiz tugagan taqdirda bankrotlik xavfini minimallashtiradi. Qarz va kapital o'rtasidagi kengayayotgan farq jiddiy moliyaviy bosimdan dalolat beradi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SEPN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Pieris Corp PVLA|SVRA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati rigel.com|ANAB (AnaptysBio) - Uzoq muddatli qarzning kapitalga nisbati|Astria Therapeutics Inc (ATXS) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati enGene Bio (ENGN)|rapt.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati JBIO (Aerovate Therapeutics)|Uzoq muddatli qarzning kapitalga nisbati aclaristx.com ACRS|Kyverna Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Tiziana Life Sciences Ltd. TLSA|CABA (Cabaletta Bio, Inc) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Ventyx Biosciences, Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|THTX (Theratechnologies Inc.) - Uzoq muddatli qarzning kapitalga nisbati|avalotx.com (AVTX) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Eledon Pharmaceuticals, Inc. (ELDN)|Uzoq muddatli qarzning o'z kapitaliga nisbati Agenus, Inc. AGEN|Uzoq muddatli qarzning o'z kapitaliga nisbati Climb Bio, Inc. CLYM|ZURA - Uzoq muddatli qarzning o'z kapitaliga nisbati|ATYR: Uzoq muddatli qarzning o'z kapitaliga nisbati|ADAG - Uzoq muddatli qarzning kapitalga nisbati|ikenaoncology.com (IMA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi STTK|Uzoq muddatli qarzning o'z kapitaliga nisbati Equillium Inc|Uzoq muddatli majburiyatlarning kapitalga nisbati Connect Pharma CNTB|Uzoq muddatli qarzning o'z kapitaliga nisbati IMUX (Immunic, Inc.)|Uzoq muddatli kreditlarning kapitalga nisbati ATRA|Uzoq muddatli qarzning kapitalga nisbati IFRX (InflaRx)|Uzoq muddatli qarzning kapitalga koeffitsiyenti XFOR|Adicet - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Celularity Inc.|INmune Bio, Inc. (INMB) - Uzoq muddatli qarzning o'z kapitaliga nisbati|barinthusbio.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|KZR (Kezar Life Sciences, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati SAB Biotherapeutics Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Akari Therapeutics plc (AKTX)|ENLV: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati QTTB (Q32 Bio)|geovax.com (GOVX) - Uzoq muddatli majburiyatlarning kapitalga nisbati|EDSA: Uzoq muddatli qarzning o'z kapitaliga nisbati|IBIO - Uzoq muddatli qarzning kapitalga nisbati|CARM (carismatx.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|XTLB: Uzoq muddatli kreditlarning kapitalga nisbati|BOLT (Bolt Biotherapeutics Inc.) - Uzoq muddatli qarzning kapitalga nisbati|HCW Biologics Inc (HCWB) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati APVO|Uzoq muddatli qarzning o'z kapitaliga nisbati aimimmuno.com AIM|Uzoq muddatli qarzning o'z kapitaliga nisbati Aditxt, Inc. ADTX|Uzoq muddatli qarzdorlikning kapitalga nisbati GRI Bio Corporation (GRI)|XRTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati reshapelifesciences.com HIND|REVB: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Indaptus Therapeutics Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati CalciMedica Inc|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi AFMD (Affimed Therapeutics)|Uzoq muddatli qarzning kapitalga nisbati ALLK|Uzoq muddatli qarzdorlikning kapitalga nisbati hookipapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati IGM Biosciences IGMS|ITOS (iTeos Therapeutics Inc) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Ocean Bio - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TCBP (TC BioPharm Ltd)|THRD: Uzoq muddatli qarzning kapitalga nisbati